- Goldman Sachs: China Is Beating the U.S. in the Gene Editing Arms RaceOn hot technologies like CRISPR and CAR-T, China has a leg up, Goldman says.
- Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?One price watchdog group says no.
- The FDA Just Approved a 2nd Revolutionary Gene Therapy. A 3rd Is Probably on the WayThe FDA approved Gilead's novel cancer-fighting gene therapy.
- The Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.FDA approves Novartis treatment that reengineers human cells to kill cancer
- Gilead's Deal to Buy Kite Pharma Is a Game-ChangerKite Pharma stock rose 29% on the news.
- FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers"I think this is the most exciting thing I have seen in my lifetime," said one FDA panel expert.
- 3 Key Takeaways from the World's Biggest Cancer ConferencePromising cancer drugs took center stage at ASCO 2017, which wraps up Tuesday.
Skip to Content